Bioisosteric modification of Linezolid identified the potential M. tuberculosis protein synthesis inhibitors to overcome the myelosuppression and serotonergic toxicity associated with Linezolid in the treatment of the multi-drug resistance tuberculosis (MDR-TB)

利奈唑啉 药理学 毒性 化学 急性毒性 药品 对接(动物) 医学 生物 万古霉素 细菌 金黄色葡萄球菌 兽医学 有机化学 遗传学
作者
Rukaiyya Girase,Iqrar Ahmad,Harun Patel
出处
期刊:Journal of Biomolecular Structure & Dynamics [Informa]
卷期号:: 1-16 被引量:6
标识
DOI:10.1080/07391102.2023.2203254
摘要

Linezolid is the first and only oxazolidinone antibacterial drug was approved in the last 35 years. It exhibits bacteriostatic efficacy against M. tuberculosis and is a crucial constituent of the BPaL regimen (Bedaquiline, Pretomanid, and Linezolid), which was authorized by the FDA in 2019 for the treatment of XDR-TB or MDR-TB. Despite its unique mechanism of action, Linezolid carries a considerable risk of toxicity, including myelosuppression and serotonin syndrome (SS), which is caused by inhibition of mitochondrial protein synthesis (MPS) and monoamine oxidase (MAO), respectively. Based on the structure toxicity relationship (STR) of Linezolid, in this work, we used a bioisosteric replacement approach to optimize the structure of Linezolid at the C-ring and/or C-5 position for myelosuppression and serotogenic toxicity. Extensive hierarchical multistep docking, drug likeness prediction, molecular binding interactions analyses, and toxicity assessment identified three promising compounds (3071, 7549 and 9660) as less toxic potential modulators of Mtb EthR protein. Compounds 3071, 7549 and 9660 were having the significant docking score of -12.696 Kcal/mol, -12.681 Kcal/mol and -15.293 Kcal/mol towards the Mtb EthR protein with less MAO-A and B affinity [compound 3071: MAO A (-4.799 Kcal/mol) and MAO B (-6.552 Kcal/mol); compound 7549: MAO A (> -2.00 Kcal/mol) and MAO B (> -2.00 Kcal/mol) and compound 9660: MAO A (> -5.678 Kcal/mol) and MAO B (> -6.537Kcal/mol) and none of them shown the Leukopenia as a side effect due to the Myelosuppression. The MD simulation results and binding free energy estimations correspond well with docking analyses, indicating that the proposed compounds bind and inhibit the EthR protein more effectively than Linezolid. The quantum mechanical and electrical characteristics were evaluated using density functional theory (DFT), which also demonstrated that the proposed compounds are more reactive than Linezolid.Communicated by Ramaswamy H. Sarma.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研友_ZbPmmL发布了新的文献求助10
刚刚
cnspower发布了新的文献求助10
1秒前
lin发布了新的文献求助10
2秒前
阿萨德完成签到,获得积分10
3秒前
美丽的平萱完成签到,获得积分10
3秒前
Gakay完成签到,获得积分10
3秒前
鱼香rose盖饭完成签到,获得积分10
4秒前
Daisy666完成签到,获得积分20
5秒前
开放的巨人完成签到 ,获得积分10
7秒前
11秒前
lin完成签到,获得积分10
14秒前
Cinde完成签到,获得积分10
16秒前
dong东包完成签到,获得积分20
18秒前
悦耳小懒猪完成签到,获得积分10
18秒前
19秒前
21秒前
飘雪发布了新的文献求助10
23秒前
小胖子完成签到 ,获得积分10
24秒前
正直夜安完成签到 ,获得积分10
25秒前
乐天林完成签到 ,获得积分10
26秒前
uracil97完成签到,获得积分10
26秒前
银色星辰完成签到,获得积分10
26秒前
TNT发布了新的文献求助10
27秒前
合适的毛豆完成签到,获得积分10
27秒前
Fun完成签到,获得积分10
28秒前
zyfqpc完成签到,获得积分10
28秒前
笨笨鲜花完成签到,获得积分10
28秒前
32秒前
搜集达人应助无奈的萍采纳,获得10
33秒前
SYT完成签到,获得积分10
33秒前
34秒前
37秒前
上弦月完成签到 ,获得积分10
37秒前
大气吐司完成签到 ,获得积分10
37秒前
皮蛋瘦肉周完成签到,获得积分10
38秒前
等你来应助ELLA采纳,获得200
39秒前
scot应助holly采纳,获得10
46秒前
yliaoyou完成签到,获得积分10
46秒前
47秒前
51秒前
高分求助中
Formgebungs- und Stabilisierungsparameter für das Konstruktionsverfahren der FiDU-Freien Innendruckumformung von Blech 1000
The Illustrated History of Gymnastics 800
The Bourse of Babylon : market quotations in the astronomical diaries of Babylonia 680
Division and square root. Digit-recurrence algorithms and implementations 500
The role of a multidrug-resistance gene (lemdrl) in conferring vinblastine resistance in Leishmania enriettii 330
Elgar Encyclopedia of Consumer Behavior 300
機能營養學前瞻(3 Ed.) 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2510436
求助须知:如何正确求助?哪些是违规求助? 2159984
关于积分的说明 5530420
捐赠科研通 1880196
什么是DOI,文献DOI怎么找? 935675
版权声明 564224
科研通“疑难数据库(出版商)”最低求助积分说明 499584